Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses

Basel, January 27, 2015 – Commenting on the results, Joseph Jimenez, CEO of Novartis, said: “2014 was a transformational year for Novartis. We improved our execution, while taking steps to focus the company on our three leading businesses with global scale. We delivered solid sales growth with margin expansion, strengthened innovation, and advanced our quality and productivity agendas. I’m confident that we are positioned for future success.”

  • Net sales grew in FY 2014, with strong core[1] margin expansion
    • Net sales increased 1% (+3% cc[1 …
/by